As of Jul 31
| +0.01 / +5.41%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.45, with a high estimate of 1.45 and a low estimate of 1.45. The median estimate represents a +643.59% increase from the last price of 0.20.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.